Key Record Dates
ClinicalTrials.gov Identifier: | NCT04165317 |
---|---|
Brief Title: | Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST) |
First Submitted : | November 13, 2019 |
First Submitted that Met QC Criteria : | November 13, 2019 |
First Posted : | November 15, 2019 |
Last Update Submitted that Met QC Criteria : | January 11, 2021 |
Last Update Posted : | January 13, 2021 |